Venture Capital interview preparation
Sourcing, unit economics, term sheets, cap tables, fund economics and the India venture market. Every question is either traced to a named firm from a public candidate report, or tagged at desk level when we could not trace it — answers lead with the point, then the mechanism, then the limitation.
100 questions, mapped to the firms that asked them
- Questions
- 100
- Traced to a firm
- 31
- Firms
- 12
- Updated
- September 2026
034Why do pro rata rights matter so much to an early-stage fund?Early-stage VCSeed funds
Say this
Because in a power-law portfolio the money is made by putting more into the one company that is working, and pro rata is the contractual right to do that. It is the cheapest option you will ever own: the right, not the obligation, to buy more of a company you already know better than any new investor.
Then walk it
- What it is: the right to maintain your ownership percentage by participating in future rounds at the new price. Not a discount — you pay the new round price. The value is access, not price.
- Why it is so valuable: after two years on the cap table you have information no incoming investor has. You know whether the metrics are real and whether the founder tells you bad news early. Exercising pro rata on your best company is the highest-information investment decision available to you.
- The maths of a seed fund depends on it. A $50m seed fund writing $1m cheques into fifty companies gets diluted to nothing by Series C unless it follows on. Reserving half the fund for follow-ons into the top five names is how the return actually gets built.
- It becomes contested precisely when it matters. In a hot round the new lead wants the whole allocation and will pressure the company to cut earlier investors. A hard pro rata right, ideally with a super pro rata provision at seed, is the only defence.
- The catch is capital: the right is worthless if you have not reserved for it. Funds that deployed 100 percent into initial cheques end up selling their pro rata to an SPV or letting it lapse, which is a real and recurring way seed funds underperform.
- One honest limitation: pro rata can also be a trap. The psychological pull to follow on into a company you already own, because you know it and you are anchored on your entry price, is strong. The discipline is to re-underwrite it as a fresh investment at the new price, and pass if you would not buy in cold.
Where candidates lose it
Describing pro rata as a right to buy at the old price. It is not — you pay the new price. And treating it as a minor administrative term. In the follow-up the interviewer will ask how much of the fund you would reserve for it, so have a number and a reason.
Expect next
- How much of a $100m fund would you reserve for follow-ons?
- When would you deliberately not exercise your pro rata?
- What is a super pro rata right and when would you ask for one?
038Valuation cap or discount — which one binds, and when would you prefer a convertible note over a SAFE?Early-stage VCSeed funds
Say this
The cap binds whenever the next round prices above the cap divided by one minus the discount, which in practice means the cap binds in any round that goes well. You take whichever gives you more shares. A note instead of a SAFE when you want a maturity date, interest, or creditor standing.
Then walk it
- Worked comparison. $10m cap, 20 percent discount, next round prices at $40m post-money. The cap gives you shares as if you bought at $10m. The discount gives you $32m. The cap wins by a wide margin, and it usually does.
- The crossover: the discount only wins if the round prices below the cap divided by 0.8, so with a $10m cap the discount only matters below $12.5m. Since most seed investors set caps well below what they expect the Series A to be, the discount is near-decorative.
- So in diligence, read the cap and treat the discount as a footnote. And if a SAFE has no cap at all, the investor is taking whatever the next round prices at, which is a genuinely bad deal masquerading as founder-friendly.
- Why choose a note. A note is debt: it accrues interest, typically 5 to 8 percent, and it has a maturity date, usually 18 to 24 months. That maturity is leverage — if no priced round happens, you can demand repayment or renegotiate from a position of strength.
- So the rule of thumb: SAFE when you trust the founder and the company is clearly on a path to a priced round; note when the company might drift, when you want creditor seniority in a wind-down, or when local law makes SAFEs awkward.
- That last point matters in India. SAFEs are a US construct and the Indian equivalent is usually a compulsorily convertible preference share or a CCD, structured to satisfy FEMA pricing rules for a non-resident investor. So a fund investing into an Indian-domiciled company generally cannot just paper a standard SAFE, which is one of several reasons companies flip to Delaware.
Where candidates lose it
Saying you take the lower of the two, or reasoning about price instead of share count. You take whichever yields more shares, which is the lower effective valuation. And not knowing that a note has a maturity date while a SAFE does not — that is the only structural difference that ever changes an outcome.
Expect next
- What happens at a note's maturity if no round has happened?
- Why can't you use a standard SAFE in India?
- Would you invest on an uncapped SAFE?
040Explain drag-along and tag-along rights, and who each one protects.Growth equityIndian venture capital
Say this
Drag-along lets a defined majority force everyone else to sell on the same terms, which protects the deal from being blocked by a small holdout. Tag-along lets a minority join a sale a larger holder has negotiated, which protects them from being left behind in a company controlled by a new owner.
Then walk it
- Drag-along: if holders of, say, a majority of preferred plus the board approve a sale, all other shareholders must sell. Without it, an acquirer who needs 100 percent of the shares can be held hostage by a former employee with 0.3 percent.
- The negotiation on drag is the threshold and the carve-outs. Founders push for a high threshold and a minimum price, so they cannot be dragged into a cheap sale that pays the preference and leaves common with nothing. That protection is reasonable and usually granted.
- Tag-along, sometimes co-sale: if a major shareholder sells, minority holders can participate pro rata on the same terms. It stops the founder or a large fund quietly selling control while leaving small holders as minorities under a stranger.
- So the asymmetry is simple: drag protects the majority's ability to transact, tag protects the minority's ability to exit. Most term sheets contain both, aimed at different risks.
- In practice the term that gets used far more often is drag, and the moment it matters is a mediocre exit. A $70m sale with a $60m preference stack means the common gets almost nothing, and the only reason it closes at all is that drag prevents the founders from refusing.
- One India-specific note: Indian shareholders' agreements carry both, and enforceability against a non-signatory has been litigated, so the articles of association have to reflect the SHA. A drag right that exists only in the SHA and not in the articles is a much weaker right, and that is a standard diligence check on an Indian cap table.
Where candidates lose it
Getting them the wrong way round, which happens constantly under pressure. Anchor it: drag drags you along, tag lets you tag along. And know why founders negotiate a minimum price into the drag, because that is the point where the term stops being boilerplate and starts deciding whether anyone on the team gets paid.
Expect next
- What threshold would you want on a drag-along?
- Why would a founder want a minimum price in the drag?
- What is a right of first refusal and how does it interact with these?
045How much should founders own at IPO, and why does it matter to you as an early investor?Growth equityLate-stage VC
Say this
Somewhere in the ten to twenty percent range for the founding team collectively is typical and healthy. It matters because below roughly ten percent the founders' incentive to grind out the last five years of value creation weakens badly, and that is a risk sitting in your position, not theirs.
Then walk it
- The arithmetic of a normal path: five or six rounds at 15 to 25 percent dilution each, plus pool top-ups, takes a founding team from 100 percent to the teens. Two founders splitting 15 percent at IPO is a perfectly standard outcome.
- Why the floor matters. A CEO with 3 percent of a company worth $2bn has $60m, which is life-changing, and the marginal incentive to spend another five years doubling it is much weaker than for someone holding 15 percent. Boards deal with this by issuing large new grants, which dilutes you again.
- So as an early investor I care about founder ownership for a purely selfish reason: it determines whether the person driving my biggest position is still motivated in year eight, and whether the company will have to spend equity to re-motivate them.
- This is one of the strongest arguments for capital efficiency. Every unnecessary round costs the founders 15 to 20 percent of what they hold, and the cheapest way to protect founder ownership is to need less money.
- It also shapes how I think about secondaries. Letting a founder sell 5 to 10 percent of their holding in a later round takes personal financial pressure off and often makes them bolder rather than lazier. I would generally support a modest, capped founder secondary rather than watch them make risk-averse decisions.
- The honest caveat: there is no magic threshold and plenty of enormous companies IPO'd with founders in single digits, sometimes with dual-class shares that preserve control while the economics diluted. Control and economics are separable, and dual-class structures are how that gets handled in practice.
Where candidates lose it
Treating this as a founder-welfare question. The interviewer wants to hear that founder ownership is a risk factor in your own position. And if you cannot connect it to capital efficiency and to dual-class control structures, the answer stays superficial.
Expect next
- How would you feel about a founder selling secondary at Series C?
- What does dual-class stock do here?
- How many rounds is too many?
046If a company raises one hundred dollars of debt and buys back one hundred dollars of shares, what happens to enterprise value and equity value?Silver LakeTechnology, Media and Telecom · San Francisco · 2022
Say this
Enterprise value is unchanged and equity value falls by one hundred. Nothing happened to the operating business, so enterprise value cannot move. Debt went up by 100, cash is unchanged because it went straight out to shareholders, so net debt is up 100 and the equity is down 100.
Then walk it
- Enterprise value equals equity value plus net debt. It is a measure of the operating asset, and neither raising debt nor buying stock changes the cash flows that asset produces.
- Trace the cash. Raise $100 of debt: cash up 100, debt up 100, net debt unchanged, enterprise value unchanged, equity value unchanged. Then spend the $100 buying shares: cash down 100, so net debt is now up 100.
- Since enterprise value is fixed, equity value must fall by 100. And that is right — you handed $100 to the shareholders who sold, so the remaining equity is worth $100 less in aggregate.
- Now the part that catches people: share price should not change in a frictionless world. The aggregate equity fell 100 and the share count fell by 100 divided by the price, so value per remaining share is the same. The shareholder is not richer; the composition of their claim changed.
- Then the real-world second-order effects worth naming. The tax shield on the new debt has genuine value, which nudges enterprise value up. Higher leverage raises the cost of equity and the risk of distress, which nudges it down. Net effect is small at low leverage and negative at high leverage.
- And EPS goes up, which is why companies do it, and why buybacks get announced as if value was created. Fewer shares and only a partial earnings hit from after-tax interest. Accretive to EPS, roughly neutral to value. That distinction is the entire point of the question.
Where candidates lose it
Saying enterprise value falls because debt rose. Debt is in the bridge from enterprise value to equity value, not in enterprise value itself. The second trap is saying the share price rises because there are fewer shares — the aggregate equity fell by the same amount, so per share it is a wash before you get to the tax shield.
Expect next
- What happens to earnings per share?
- Does the share price change? Why not?
- At what leverage level would enterprise value actually fall?
Reported by candidates at Silver Lake (Technology, Media and Telecom, San Francisco, 2022). Source: Wall Street Oasis.
048What goes into a fully diluted share count, and why do you insist on it?Growth equity
Say this
Common shares, all preferred on an as-converted basis, all issued options whether vested or not, the entire unissued option pool, warrants, and any SAFEs or notes converted at their caps. Everything that will one day be a share. You insist on it because every other denominator understates your dilution.
Then walk it
- Common: founders and anyone who has exercised. Preferred: converted one-for-one unless there has been an anti-dilution adjustment, in which case at the adjusted ratio.
- Options: all granted options, vested or not, plus the unissued pool. Including the unissued pool is what makes it fully diluted rather than merely as-converted, and it is the line founders most often leave out.
- Convertible instruments: SAFEs and notes converted at whichever of their cap or discount gives more shares, plus accrued interest on notes. If the company has $4m of outstanding SAFEs, they are shares and pretending otherwise misstates your position by several points.
- Warrants, including anything issued to a venture debt lender. Venture debt typically carries warrant coverage of 10 to 25 percent of the loan amount, and it is easy to miss in a data room.
- Why it matters practically: your ownership, the preference stack, and every per-share number in the waterfall depend on the denominator. A term sheet that says 20 percent on a basic share count and 16 percent fully diluted is a materially different deal, and the document will always say fully diluted.
- So in diligence I would rebuild the cap table myself from the underlying documents rather than accept the founder's spreadsheet. It is the single most common place where numbers are wrong, usually honestly — a founder who has raised on four SAFEs and two notes often genuinely does not know their own fully diluted number.
Where candidates lose it
Forgetting the unissued option pool, or forgetting warrants attached to venture debt. Both are real shares. And accepting the company's cap table at face value — rebuilding it is table stakes for an associate, and saying you would do it is part of the answer.
Expect next
- How do you handle warrants from a venture debt facility?
- What is the difference between as-converted and fully diluted?
- Where do founders' cap tables usually go wrong?
049Why is it difficult to value a first-year company?Sequoia CapitalVenture Capital · San Francisco · 2021
Say this
Because every valuation technique needs either cash flows or comparable multiples, and a first-year company has neither. There is no history to extrapolate, the distribution of outcomes is bimodal rather than a range, and the discount rate that would compensate for the risk is so high that a DCF produces nonsense.
Then walk it
- No cash flows to discount. A DCF on a company with $200k of revenue puts 98 percent of the value in a terminal value ten years out, which means you are not valuing anything — you are writing down a guess and discounting it.
- No usable comparables. The company may be the first of its kind, and where comparables exist, a revenue multiple on a base of $200k gives you a number that moves by millions if the revenue moves by a rounding error.
- The outcome distribution is the deeper problem. A mature company's value is a range around a central case. A seed company is mostly zero with a small chance of being enormous, and an expected value calculated across a bimodal distribution does not describe any world that will actually happen.
- Risk is unpriceable in the normal way. The implied discount rate on seed-stage capital is somewhere between 40 and 80 percent a year. Nobody can defend a specific number in that band, and the valuation output is entirely determined by which one you pick.
- So what actually sets the price is not valuation at all: it is the amount the company needs for eighteen to twenty-four months, divided by the dilution the founder will accept, cross-checked against what similar rounds are clearing at this quarter. Price follows round size, not the other way round.
- And the investor's genuine frame is the reverse question: forget what it is worth, what does it need to become for this cheque to return the fund? At a $5m post-money for 20 percent, a $200m fund needs an exit near $1bn. Whether that is plausible is the actual decision, and it is answerable in a way that 'what is it worth' is not.
Where candidates lose it
Answering only 'there's no financial history'. True and shallow. The strong answer names the bimodal outcome distribution, the indefensible discount rate, and then flips to how seed prices are actually set — by round size and market convention, not by valuation technique. Then close with the fund-return test.
Expect next
- So how do you actually set the price?
- What is the venture method?
- What would you need to believe for a $5m post-money to be a good deal?
Reported by candidates at Sequoia Capital (Venture Capital, San Francisco, 2021). Source: Wall Street Oasis.
050How do you value a pre-revenue company?Early-stage VCSeed funds
Say this
Backwards from the exit, not forwards from the fundamentals. Pick a plausible exit value and multiple, work out the ownership you need at exit to make the return your fund requires, gross that up for future dilution, and that tells you the entry price you can pay.
Then walk it
- This is the venture method. Say a plausible exit is $500m in eight years. My fund needs this position to return $100m, so I need 20 percent at exit.
- Gross up for dilution. Three more rounds at 20 percent each means my position shrinks by a factor of about 0.51, so I need roughly 39 percent today to hold 20 percent at exit — or I need pro rata rights and reserves to defend it, which is usually the more realistic path.
- If 39 percent is unbuyable, which it normally is, then either the exit assumption is too small for the cheque size, or I write a smaller cheque, or I pass. That is a useful, disciplined conclusion and it is what the method is for.
- Cross-check against three market anchors: what comparable rounds at this stage and geography are clearing at this quarter, the last round price if there was one, and replacement cost — what it would cost to build this team and product from scratch, which sets a rough floor for an acquihire.
- Then the qualitative adjustments that actually move seed prices: team pedigree, competitive tension in the round, and whether a brand-name fund is circling. A seed round with two term sheets prices 40 percent higher than the same company with one, and pretending otherwise is dishonest about how the market works.
- And say the limitation plainly: this produces a range, not a number, and the range is wide. The honest version is that seed valuation is a negotiation anchored on round size and convention, and the venture method is a discipline for knowing when to walk away rather than a pricing model.
Where candidates lose it
Reaching for a DCF. With no revenue, a DCF is a terminal value with a decorative forecast in front of it. And building the venture method without grossing up for future dilution — that step is what makes the answer usable, and skipping it is the most common error.
Expect next
- How much dilution would you assume between now and exit?
- How does the answer change for a deep tech company with a ten-year horizon?
- What if a competitor is bidding and the price is 50 percent higher?
051How do you value a company on ARR multiples, and when does that break?Growth equitySaaS-focused funds
Say this
Enterprise value divided by annual recurring revenue, benchmarked against public comparables and recent private rounds, then adjusted for growth and retention. It breaks the moment the revenue is not actually recurring, and it breaks completely as a cross-sectional comparison because the multiple is a function of growth.
Then walk it
- The mechanics: take ARR, not trailing revenue — the annualised value of contracted subscriptions at a point in time. Apply a multiple from public SaaS comparables, discount it for private illiquidity and scale, then adjust up or down for growth and net retention.
- Growth is what the multiple is really pricing. Public software has historically traded at roughly 4 to 8 times forward revenue for 20 percent growers and 12 to 20 times for 40 percent-plus growers with good retention. Those bands have moved violently — in 2021 the top decile traded above 30 times, and the same companies traded under 10 times eighteen months later with unchanged fundamentals.
- That volatility is the first thing that breaks it: the multiple is a market-sentiment variable, so an ARR multiple set at the top of a cycle is not a valuation, it is a timestamp.
- Second break: the recurring claim. Usage-based revenue, services revenue dressed up as subscription, annual contracts with no auto-renewal, or a revenue base where the top ten customers are on pilots — none of these are ARR, and companies routinely present them as such. Ask for contracted, auto-renewing revenue only.
- Third break: it ignores the cost of getting the revenue. Two companies at $20m of ARR growing 50 percent are the same on this metric and completely different if one has a burn multiple of 1.2 and the other 4. That is why the multiple always has to be read against efficiency and retention.
- So how I would actually use it: as a sanity check and a market-clearing reference, never as the primary output. The primary work is the growth durability and retention case, and the multiple is what translates that into a price the market will accept this quarter.
Where candidates lose it
Quoting a multiple band without saying that it is a function of growth and retention, and without acknowledging how far those bands moved between 2021 and 2023. Also accepting the company's ARR definition — interrogating what is actually recurring is most of the real work.
Expect next
- What would you accept as ARR and what would you strip out?
- Would you pay a higher multiple for 40 percent growth or 130 percent net retention?
- How do you value a usage-based pricing model?
056Explain the power law and what it actually means for how you vote in a partners' meeting.Early-stage VCSeed funds
Say this
Venture returns are not normally distributed — a small number of investments produce most of the return, and roughly half return less than the capital invested. It means the only question that matters in a partners' meeting is whether this company could return the fund, not whether it is likely to lose money.
Then walk it
- The shape: across a typical early-stage portfolio, something like 50 to 60 percent of investments return less than 1x, a middle band returns 1 to 3x, and one or two return 10x or more and produce the majority of the fund's gains.
- So the asymmetry is total. The downside of any single investment is capped at 1x of a small cheque; the upside is unbounded. That means the cost of a false negative — passing on the outlier — is enormously higher than the cost of a false positive.
- Which changes the question you ask. Not 'what is the probability this works' but 'if it works, is it big enough to return the fund?' A company with a 60 percent chance of becoming a $200m business is a worse portfolio decision than one with a 10 percent chance of becoming a $10bn business.
- This is why consensus voting is dangerous in venture. The companies that produce outlier returns are usually the ones that divide the partnership, because by definition consensus ideas are priced. A firm where every investment is unanimous is probably screening out its best decisions.
- It also dictates reserves. If one company will produce most of the return, the right behaviour is to concentrate follow-on capital into the names that are working and stop funding the middle. The hardest discipline in the job is refusing to feed a decent company that will never be an outlier.
- The limitation worth naming: the power law is a description of outcomes, not a licence for recklessness. It gets misused to justify paying any price for anything with a big story. The constraint is still that the portfolio has to be constructed so that one outlier is enough — which means enough shots, and enough ownership in each.
Where candidates lose it
Reciting 'one investment returns the fund' as a slogan. The interviewer wants the consequences: how it changes the question you ask in diligence, why it argues against consensus decisions, and what it implies for reserves. And you should name the misuse of it, because 'power law' has become the standard excuse for undisciplined pricing.
Expect next
- How many investments does a fund need for the power law to work?
- So would you back a company the whole partnership disliked?
- What does this mean for how you allocate reserves?
Firm tags come from public, anonymous candidate reports on Wall Street Oasis: strong signal, not sworn testimony. Firms are named as the places a question was reported, not as partners of Fin Maverick. Answers are written for this page to show how to think out loud; they are not scripts to recite.
